BioGaia AB (FRA:BGLA) Cash Flow for Dividends : €-61.7 Mil (TTM As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Cash Flow for Dividends?

BioGaia AB's cash flow for dividends for the three months ended in Sep. 2024 was €0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Sep. 2024 was €-61.7 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

BioGaia AB's quarterly payment of dividends increased from Mar. 2024 (€0.0 Mil) to Jun. 2024 (€-61.7 Mil) but then declined from Jun. 2024 (€-61.7 Mil) to Sep. 2024 (€0.0 Mil).

BioGaia AB's annual payment of dividends increased from Dec. 2021 (€-6.7 Mil) to Dec. 2022 (€-27.4 Mil) but then declined from Dec. 2022 (€-27.4 Mil) to Dec. 2023 (€-26.2 Mil).

BioGaia AB Cash Flow for Dividends Historical Data

The historical data trend for BioGaia AB's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Cash Flow for Dividends Chart

BioGaia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-16.54

-6.39

-6.71

-27.41

-26.18

BioGaia AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Cash Flow for Dividends	Get a 7-Day Free Trial															-	-	-	-61.73	-

BioGaia AB Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-61.7 Mil.

BioGaia AB Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (FRA:BGLA) » Definitions » Cash Flow for Dividends

Traded in Other Exchanges

BGLAF:USA BIOG B:Sweden 0GTN:UK

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.

BioGaia AB Headlines

No Headlines